Heavily pretreated ovarian cancer patients treated by single-agent gemcitabine. A retrospective outcome comparison between platinum-sensitive and platinum-resistant patients

Author： Safra Tamar   Ron Ilan   Boaz Mona   Brenner Joseph   Grisaru Dan   Inbar Moshe   Hayat Henry   Menczer Joseph   Golan Abraham   Levy Tally  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.45, Iss.4, 2006-06, pp. : 463-468

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increasing the chances for platinum-sensitive ovarian cancer patients

By González Antonio  

Future Oncology, Vol. 9, Iss. 12, 2013-12 ,pp. : 29-35

Future Medicine

Access to resources Recommend Favorite

Concerns with ''Maintenance Chemotherapy'' for Patients with Recurrent Platinum-Sensitive Ovarian Cancer

By Markman M.  

Gynecologic Oncology, Vol. 73, Iss. 3, 1999-06 ,pp. : 469-470

Elsevier

Access to resources Recommend Favorite

Secondary Cytoreductive Surgery in Patients with Platinum-Sensitive Recurrent Ovarian Cancer

By Benedetti Panici Pierluigi   De Vivo Antonio   Bellati Filippo   Manci Natalina   Perniola Giorgia   Basile Stefano   Muzii Ludovico   Angioli Roberto  

Annals of Surgical Oncology, Vol. 14, Iss. 3, 2007-03 ,pp. : 1136-1142

Springer Publishing Company

Access to resources Recommend Favorite

Activity of Gemcitabine in Platinum-resistant Ovarian Germ Cell Cancer

By Maas K.   Daikeler T.   Kanz L.   Bokemeyer C.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1437-1438

Elsevier

Access to resources Recommend Favorite

The Costs and Efficacy of Liposomal Doxorubicin in Platinum-Refractory Ovarian Cancer in Heavily Pretreated Patients

By Hensley M.L.   Hoppe B.   Leon L.   Sabbatini P.   Aghajanian C.   Chi D.   Spriggs D.R.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 464-469

Elsevier

Access to resources Recommend Favorite